NextPlat (NASDAQ:NXPL) Shares Up 1.1% – Time to Buy?

NextPlat Corp. (NASDAQ:NXPL) shares were up 1.1% during trading on Wednesday . The company traded as high as $0.6250 and last traded at $0.6144. Approximately 29,633 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 184,586 shares. The stock had previously closed at $0.6080.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of NextPlat in a research note on Monday. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

NextPlat Stock Up 1.1%

The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The firm has a fifty day simple moving average of $0.76 and a 200-day simple moving average of $0.74. The firm has a market cap of $16.16 million, a price-to-earnings ratio of -2.05 and a beta of 1.16.

NextPlat (NASDAQ:NXPL) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.08) EPS for the quarter. The company had revenue of $13.75 million during the quarter. NextPlat had a negative net margin of 14.58% and a negative return on equity of 34.22%.

Institutional Investors Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.